<b>New drugs for the treatment of agitation in schizophrenia: a systematic review and meta-analysis of inhaled loxapine and infused sodium nitroprusside
The use of novel drugs such as inhaled loxapine (LOXi) for schizophrenia and the off-label use of substances such as sodium nitroprusside (NIT) for the management of mental disorders require further investigation. We aimed to evaluate the efficacy and safety of LOXi and NIT for the treatment of agit...
Saved in:
Main Authors: | Fernanda Stumpf Tonin (Author), Thais Piazza (Author), Helena Hiemisch Lobo Borba (Author), Astrid Wiens (Author), Roberto Pontarolo (Author) |
---|---|
Format: | Book |
Published: |
Universidade Estadual de Maringá,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change
by: Bruno Pacciardi, et al.
Published: (2019) -
Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents
by: Citrome L
Published: (2013) -
Treatment interruption of biological drugs and tofacitinib in rheumatoid arthritis: A systematic review of case reports
by: Astrid Wiens, et al.
Published: (2019) -
Methylglyoxal Enhances Sodium Nitroprusside-Induced Relaxation in Rat Aorta
by: Masashi Mukohda, et al.
Published: (2010) -
Evaluation of sodium nitroprusside for controlled hypotension in children during surgery
by: David R Drover, et al.
Published: (2015)